Standout Papers

Denosumab in Postmenopausal Women with Low Bone Mineral Density 1999 2026 2008 2017 859
  1. Denosumab in Postmenopausal Women with Low Bone Mineral Density (2006)
    Michael R. McClung, E. Michael Lewiecki et al. New England Journal of Medicine
  2. Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression (2004)
    Philip J. Mease, Alan Kivitz et al. Arthritis & Rheumatism
  3. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial (2006)
    Désirée van der Heijde, Alan Kivitz et al. Arthritis & Rheumatism
  4. Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis (1999)
    Lee S. Simon, Arthur L. Weaver et al. JAMA
  5. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial (2003)
    John C. Davis, Désirée van der Heijde et al. Arthritis & Rheumatism
  6. Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study (2009)
    Xavier Chevalier, Philippe Goupille et al. Arthritis Care & Research
  7. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial (2018)
    Gerd R Burmester, Joel M. Kremer et al. The Lancet
  8. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial (2021)
    Bernard Combe, Alan Kivitz et al. Annals of the Rheumatic Diseases
  9. Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis (2022)
    Philip J. Mease, Atul Deodhar et al. Annals of the Rheumatic Diseases
  10. A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis (2023)
    Jay Tuttle, Edit Drescher et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 5 from Science/Nature 76 standout
Sub-graph 1 of 18

Citing Papers

Machine learning models to accelerate the design of polymeric long-acting injectables
2023 Standout
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
2021 Standout
10 intermediate papers

Works of Alan Kivitz being referenced

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial
2018 Standout
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
2004 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Alan Kivitz 7180 4379 3209 264 12.4k
Barry Bresnihan 7141 3964 2233 231 12.6k
Oliver FitzGerald 8496 6702 3792 468 14.2k
Douglas J. Veale 6204 4198 2161 284 12.7k
Stanley Cohen 10300 4421 4591 212 17.9k
Willem F. Lems 8260 1769 1680 398 14.5k
Jochen Zwerina 4649 2256 1038 225 11.9k
Zoltán Szekanecz 5462 3346 1210 323 11.8k
Christopher T. Ritchlin 9763 9281 5243 342 14.7k
Naoyuki Kamatani 4312 2441 1269 336 13.3k
Michel Malaise 4144 1538 1371 198 8.3k

All Works

Loading papers...

Rankless by CCL
2026